Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2025-12-24 @ 10:00 PM
NCT ID:
NCT00393432
Eligibility Criteria:
* INCLUSION CRITERIA:
1. Age between 18-55 years
2. Able to perform tasks required by the study
3. Willing and able to give consent
4. Possibility to obtain TMS-evoked thumb movements in a consistent direction at baseline
EXCLUSION CRITERIA:
Subjects are not eligible for this experiment if they:
1. Are unable to perform the tasks
2. Have history of severe alcohol or drug abuse, psychiatric illness like severe depression and poor motivational capacity
3. Have problems with movement of the hands
4. Are receiving drugs acting primarily on the central nervous system
5. Are pregnant
6. Have medical or technical contraindications to MRI procedures or devices producing artifacts that impair MRI signal (e.g., dental braces, pacemakers, implanted medication pumps, cochlear devices, neural stimulators, metal in the cranium, surgical clips, and other metal/magnetic implants, claustrophobia)
7. Have had an allergic reaction to scopolamine. Have glaucoma, severe liver disease, kidney disease, an enlarged prostrate gland or a blocked digestive tube
8. Have had an allergic reaction to dextromethorphan
9. Are using a MAO inhibitor (such as Parnate \[registered trademark\], Nardil \[registered trademark\], or Marplan \[registered trademark\] or if you have used one of these drugs in the past 2 weeks
10. Have asthma
11. Are taking pain or arthritis medicine (sometimes called NSAIDs) such as aspirin, ibuprofen, or naproxen on a regular basis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00393432
Study Brief:
Protocol Section:
NCT00393432